Molecular and Environmental Sciences Group, Department of Geological Sciences, College of Arts and Science, University of Saskatchewan, 114 Science Place, Saskatoon, SaskatchewanS7N 5E2, Canada.
Department of Chemistry, College of Arts and Science, University of Saskatchewan, 110 Science Place, Saskatoon, SaskatchewanS7N 5C9, Canada.
Inorg Chem. 2022 Sep 19;61(37):14626-14640. doi: 10.1021/acs.inorgchem.2c01694. Epub 2022 Sep 8.
Although Alzheimer's disease (AD) was first described over a century ago, it remains the leading cause of age-related dementia. Innumerable changes have been linked to the pathology of AD; however, there remains much discord regarding which might be the initial cause of the disease. The "amyloid cascade hypothesis" proposes that the amyloid β (Aβ) peptide is central to disease pathology, which is supported by elevated Aβ levels in the brain before the development of symptoms and correlations of amyloid burden with cognitive impairment. The "metals hypothesis" proposes a role for metal ions such as iron, copper, and zinc in the pathology of AD, which is supported by the accumulation of these metals within amyloid plaques in the brain. Metals have been shown to induce aggregation of Aβ, and metal ion chelators have been shown to reverse this reaction . 8-Hydroxyquinoline-based chelators showed early promise as anti-Alzheimer's drugs. Both 5-chloro-7-iodo-8-hydroxyquinoline (CQ) and 5,7-dichloro-2-[(dimethylamino)methyl]-8-hydroxyquinoline (PBT2) underwent unsuccessful clinical trials for the treatment of AD. To gain insight into the mechanism of action of 8HQs, we have investigated the potential interaction of CQ, PBT2, and 5,7-dibromo-8-hydroxyquinoline (B2Q) with Cu(II)-bound Aβ(1-42) using X-ray absorption spectroscopy (XAS), high energy resolution fluorescence detected (HERFD) XAS, and electron paramagnetic resonance (EPR). By XAS, we found CQ and B2Q sequestered ∼83% of the Cu(II) from Aβ(1-42), whereas PBT2 sequestered only ∼59% of the Cu(II) from Aβ(1-42), suggesting that CQ and B2Q have a higher relative Cu(II) affinity than PBT2. From our EPR, it became clear that PBT2 sequestered Cu(II) from a heterogeneous mixture of Cu(II)Aβ(1-42) species in solution, leaving a single Cu(II)Aβ(1-42) species. It follows that the Cu(II) site in this Cu(II)Aβ(1-42) species is inaccessible to PBT2 and may be less solvent-exposed than in other Cu(II)Aβ(1-42) species. We found no evidence to suggest that these 8HQs form ternary complexes with Cu(II)Aβ(1-42).
尽管阿尔茨海默病(AD)在一个多世纪前就已被首次描述,但它仍是与年龄相关的痴呆症的主要原因。无数的变化与 AD 的病理学有关;然而,对于哪种变化可能是疾病的最初原因,仍然存在很大的争议。“淀粉样蛋白级联假说”提出,淀粉样β(Aβ)肽是疾病病理学的核心,这一假说得到了在出现症状之前大脑中 Aβ水平升高以及淀粉样斑块中的淀粉样蛋白负荷与认知障碍的相关性的支持。“金属假说”提出,铁、铜和锌等金属离子在 AD 的病理学中起作用,这一假说得到了大脑中淀粉样斑块内这些金属的积累的支持。已经表明金属可以诱导 Aβ聚集,并且金属离子螯合剂已被证明可以逆转这种反应。基于 8-羟基喹啉的螯合剂作为抗阿尔茨海默病药物显示出早期的希望。5-氯-7-碘-8-羟基喹啉(CQ)和 5,7-二氯-2-[(二甲基氨基)甲基]-8-羟基喹啉(PBT2)均因治疗 AD 的临床试验失败而未被采用。为了深入了解 8HQ 的作用机制,我们使用 X 射线吸收光谱(XAS)、高能分辨荧光探测(HERFD)XAS 和电子顺磁共振(EPR)研究了 CQ、PBT2 和 5,7-二溴-8-羟基喹啉(B2Q)与 Cu(II)结合的 Aβ(1-42)之间的潜在相互作用。通过 XAS,我们发现 CQ 和 B2Q 从 Aβ(1-42)中螯合了约 83%的 Cu(II),而 PBT2 仅从 Aβ(1-42)中螯合了约 59%的 Cu(II),这表明 CQ 和 B2Q 对 Cu(II)的亲和力比 PBT2 高。从我们的 EPR 中可以清楚地看出,PBT2 从溶液中 Cu(II)-Aβ(1-42)的异构混合物中螯合 Cu(II),留下单一的 Cu(II)-Aβ(1-42)物种。因此,该 Cu(II)-Aβ(1-42)物种中的 Cu(II)位点对 PBT2 不可访问,并且比其他 Cu(II)-Aβ(1-42)物种中的 Cu(II)位点更不易受溶剂影响。我们没有发现这些 8HQ 与 Cu(II)-Aβ(1-42)形成三元配合物的证据。